世界および米国の医薬品向けCRO(Contract Research Organization)およびCDMOの市場規模、現状、予測2021-2027年

Global and United States Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size, Status and Forecast 2021-2027

市場分析と洞察。世界の医薬品向けCRO（Contract Research Organization）およびCDMO（Contract Research Organization）市場について世界の医薬品向けCRO（Contract Research Organization）およびCDMOの市場... もっと見る

出版社	出版年月	電子版価格	言語
QYResearch QYリサーチ	2021年12月3日	US$3,900 シングルユーザライセンスライセンス・価格情報注文方法はこちら	英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。

サマリー

市場分析と洞察。世界の医薬品向けCRO（Contract Research Organization）およびCDMO（Contract Research Organization）市場について
世界の医薬品向けCRO（Contract Research Organization）およびCDMOの市場規模は、2020年のXX百万米ドルから2021-2027年の間にXX％のCAGRで推移し、2027年にはXX百万米ドルに達すると予測されています。
本レポートは、業界標準の正確な分析と高いデータの整合性により、世界の医薬品開発業務受託機関（CRO）およびCDMO市場で得られる主要な機会を明らかにし、プレイヤーが市場での確固たる地位を獲得するのに役立つよう、見事な試みを行っています。本レポートの購入者は、世界の医薬品開発業務受託機関（CRO）およびCDMO市場全体の収益規模など、検証済みの信頼できる市場予測にアクセスすることができます。
本レポートは、世界の医薬品開発業務受託機関（CRO）およびCDMO市場において、競合他社に対して優位に立ち、永続的な成功を収めるための有効なツールであることを証明しています。本レポートに掲載されているすべての調査結果、データ、情報は、信頼できる情報源の助けを借りて検証、再検証されています。本レポートを執筆したアナリストは、世界の医薬品開発業務受託機関（CRO）およびCDMO市場を詳細に調査するために、独自の業界最高水準の調査・分析手法を用いています。

世界の医薬品開発業務受託機関(CRO)およびCDMOの範囲と市場規模
医薬品開発業務受託機関（CRO）・CDMO市場は、企業別、地域（国）別、タイプ別、アプリケーション別に分類されています。世界の医薬品開発業務受託機関（CRO）・CDMO市場に参加するプレイヤー、ステークホルダー、その他の参加者は、本レポートを強力なリソースとして活用することで、優位に立つことができるでしょう。セグメント別分析では、2016年から2027年の期間で、タイプ別とアプリケーション別の収益と予測に焦点を当てています。

タイプ別セグメント
開発分野
原薬製造
製剤化

アプリケーション別セグメント
医薬品
バイオ医薬品

地域別
北アメリカ
アメリカ
カナダ
ヨーロッパ
ドイツ
フランス
U.K.
イタリア
ロシア
北欧
その他のヨーロッパ諸国
アジア太平洋地域
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア諸国
ラテンアメリカ
メキシコ
ブラジル
その他のラテンアメリカ
中近東・アフリカ
トルコ
サウジアラビア
アラブ首長国連邦
その他の中東・アフリカ地域

会社別
レシファム
AMRI3
Patheon
Aenova
キャタレント
Amatsigroup
WuXi PharmaTech
Strides Shasun
ピラマル
ジークフリート

ページTOPに戻る

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Development
1.2.3 API production
1.2.4 Formulation
1.3 Market by Application
1.3.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Pharmaceutical
1.3.3 Biopharmaceutical
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Perspective (2016-2027)
2.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Growth Trends by Regions
2.2.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Historic Market Share by Regions (2016-2021)
2.2.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Regions (2022-2027)
2.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Industry Dynamic
2.3.1 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Trends
2.3.2 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Drivers
2.3.3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Challenges
2.3.4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Contract Research Organization (CRO) and CDMO for Pharmaceutical Players by Revenue
3.1.1 Global Top Contract Research Organization (CRO) and CDMO for Pharmaceutical Players by Revenue (2016-2021)
3.1.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue Market Share by Players (2016-2021)
3.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue
3.4 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Ratio
3.4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Contract Research Organization (CRO) and CDMO for Pharmaceutical Revenue in 2020
3.5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Key Players Head office and Area Served
3.6 Key Players Contract Research Organization (CRO) and CDMO for Pharmaceutical Product Solution and Service
3.7 Date of Enter into Contract Research Organization (CRO) and CDMO for Pharmaceutical Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Contract Research Organization (CRO) and CDMO for Pharmaceutical Breakdown Data by Type
4.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Historic Market Size by Type (2016-2021)
4.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Type (2022-2027)

5 Contract Research Organization (CRO) and CDMO for Pharmaceutical Breakdown Data by Application
5.1 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Historic Market Size by Application (2016-2021)
5.2 Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2016-2027)
6.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type
6.2.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2021)
6.2.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2022-2027)
6.2.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2027)
6.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application
6.3.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2021)
6.3.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2022-2027)
6.3.3 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2027)
6.4 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
6.4.1 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2016-2021)
6.4.2 North America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2016-2027)
7.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type
7.2.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2021)
7.2.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2022-2027)
7.2.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2027)
7.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application
7.3.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2021)
7.3.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2022-2027)
7.3.3 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2027)
7.4 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
7.4.1 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2016-2021)
7.4.2 Europe Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2016-2027)
8.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type
8.2.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2027)
8.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application
8.3.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2027)
8.4 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region
8.4.1 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2016-2027)
9.2 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type
9.2.1 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2021)
9.2.2 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2022-2027)
9.2.3 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2027)
9.3 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application
9.3.1 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2021)
9.3.2 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2022-2027)
9.3.3 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2027)
9.4 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
9.4.1 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2016-2021)
9.4.2 Latin America Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size (2016-2027)
10.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type
10.2.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Type (2016-2027)
10.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application
10.3.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Application (2016-2027)
10.4 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country
10.4.1 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Contract Research Organization (CRO) and CDMO for Pharmaceutical Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Recipharm
11.1.1 Recipharm Company Details
11.1.2 Recipharm Business Overview
11.1.3 Recipharm Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.1.4 Recipharm Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.1.5 Recipharm Recent Development
11.2 AMRI3
11.2.1 AMRI3 Company Details
11.2.2 AMRI3 Business Overview
11.2.3 AMRI3 Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.2.4 AMRI3 Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.2.5 AMRI3 Recent Development
11.3 Patheon
11.3.1 Patheon Company Details
11.3.2 Patheon Business Overview
11.3.3 Patheon Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.3.4 Patheon Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.3.5 Patheon Recent Development
11.4 Aenova
11.4.1 Aenova Company Details
11.4.2 Aenova Business Overview
11.4.3 Aenova Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.4.4 Aenova Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.4.5 Aenova Recent Development
11.5 Catalent
11.5.1 Catalent Company Details
11.5.2 Catalent Business Overview
11.5.3 Catalent Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.5.4 Catalent Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.5.5 Catalent Recent Development
11.6 Amatsigroup
11.6.1 Amatsigroup Company Details
11.6.2 Amatsigroup Business Overview
11.6.3 Amatsigroup Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.6.4 Amatsigroup Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.6.5 Amatsigroup Recent Development
11.7 WuXi PharmaTech
11.7.1 WuXi PharmaTech Company Details
11.7.2 WuXi PharmaTech Business Overview
11.7.3 WuXi PharmaTech Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.7.4 WuXi PharmaTech Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.7.5 WuXi PharmaTech Recent Development
11.8 Strides Shasun
11.8.1 Strides Shasun Company Details
11.8.2 Strides Shasun Business Overview
11.8.3 Strides Shasun Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.8.4 Strides Shasun Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.8.5 Strides Shasun Recent Development
11.9 Piramal
11.9.1 Piramal Company Details
11.9.2 Piramal Business Overview
11.9.3 Piramal Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.9.4 Piramal Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.9.5 Piramal Recent Development
11.10 Siegfried
11.10.1 Siegfried Company Details
11.10.2 Siegfried Business Overview
11.10.3 Siegfried Contract Research Organization (CRO) and CDMO for Pharmaceutical Introduction
11.10.4 Siegfried Revenue in Contract Research Organization (CRO) and CDMO for Pharmaceutical Business (2016-2021)
11.10.5 Siegfried Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

ページTOPに戻る

Table of Contents

Summary

Market Analysis and Insights: Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Market
The global Contract Research Organization (CRO) and CDMO for Pharmaceutical market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market.

Global Contract Research Organization (CRO) and CDMO for Pharmaceutical Scope and Market Size
Contract Research Organization (CRO) and CDMO for Pharmaceutical market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Contract Research Organization (CRO) and CDMO for Pharmaceutical market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Development
API production
Formulation

Segment by Application
Pharmaceutical
Biopharmaceutical

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Recipharm
AMRI3
Patheon
Aenova
Catalent
Amatsigroup
WuXi PharmaTech
Strides Shasun
Piramal
Siegfried

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野の最新刊レポート

本レポートと同分野の最新刊レポートはありません。

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（contract）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。 QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る

調査レポートの納品までの日数はどの程度ですか?

在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。

注文の手続きはどのようになっていますか?

1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。

お支払方法の方法はどのようになっていますか?

納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。

データリソース社はどのような会社ですか?

当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。

世界および米国の医薬品向けCRO(Contract Research Organization)およびCDMOの市場規模、現状、予測2021-2027年

サマリー

目次

Summary

Table of Contents

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

本レポートと同分野の最新刊レポート

QYResearch社のその他分野での最新刊レポート

本レポートと同じKEY WORD（contract）の最新刊レポート

よくあるご質問

QYResearch社はどのような調査会社ですか?

調査レポートの納品までの日数はどの程度ですか?

注文の手続きはどのようになっていますか?

お支払方法の方法はどのようになっていますか?

データリソース社はどのような会社ですか?